Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Liver Neoplasms × yttrium chloride × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Neoplasms 1 Carcinoma, Hepatocellular 1

Interventions

Sorafenib 7 Radiosurgery 6 pembrolizumab 4 Oxaliplatin 4 Cryosurgery 4 Radiotherapy, Conformal 3 Ipilimumab 3 Fluorouracil 3 Bevacizumab 3 tremelimumab 2 spartalizumab 2 lenvatinib 2 Nivolumab 2 Leucovorin 2 Injections 2 Everolimus 2 Doxorubicin 2 Cyclophosphamide 2 Carboplatin 2 Capecitabine 2 yttrium chloride 1 vofatamab 1 toripalimab 1 tocilizumab 1 sapanisertib 1 poly ICLC 1 pertuzumab 1 irofulven 1 fluoromisonidazole 1 fludarabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06725121 2024-12-16

MacroTrans

University Health Network, Toronto

Phase 1/2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡